Dr. Natasha E. Shur

Nancy Braverman is a Medical Genetics specialist and a Pediatrics provider in Baltimore, Maryland. Dr. Braverman is rated as an Elite provider by MediFind in the treatment of Zellweger Syndrome. Her top areas of expertise are Zellweger Syndrome, Chondrodysplasia Punctata Syndrome, X-Linked Chondrodysplasia Punctata 2, and Acromesomelic Dysplasia.

Dr. Gerald Raymond is a clinical geneticist and neurologist at Johns Hopkins where he is also a professor of genetic medicine and neurology. He obtained his MD at the University of Connecticut and was trained in Pediatrics at Johns Hopkins Hospital and Neurology at the Mass. General Hospital. He received additional training in developmental neuropathology at the Universite Catholique de Louvain in Belgium and clinical genetics at the Harvard Program. Dr. Raymond’s research has been at the overlap of genetics and neurology with specific focus on peroxisomal disorders including adrenoleukodystrophy. He has been actively involved in newborn screening for ALD and in developing clinical follow-up programs. He has extensive experience in clinical management of neurogenetic issues including peroxisomal and lysosomal disorders. He presently serves as the Director of the Lysosomal Storage Disease program in the department of Genetic Medicine. Dr. Raymond is rated as an Elite provider by MediFind in the treatment of Zellweger Syndrome. His top areas of expertise are Adrenoleukodystrophy (ALD), CACH Syndrome, Zellweger Syndrome, and Leukodystrophy.

Dr. Sujatha Kannan is professor of anesthesiology and critical care medicine and pediatrics at the Johns Hopkins University School of Medicine. She is also the Richard J. Traystman Endowed Chair and the Vice Chair for Research for ACCM. She specializes in pediatric critical care with expertise in pediatric neurocritical care. In addition to her role at Johns Hopkins, Dr. Kannan is also a research scientist at the Hugo Moser Researcher Institute at Kennedy Krieger Institute. Dr. Kannan completed her medical training at the Jawaharlal Institute of Post Graduate Medical Education and Research in Pondicherry, India. She conducted residencies in pediatrics at the University Illinois at Chicago and the Children’s Hospital of Michigan. Additionally, she completed a fellowship in pediatric critical care medicine at the Children’s Hospital of Michigan. Dr. Kannan joined the Johns Hopkins faculty in 2011. Her research focuses on understanding the role of inflammation and immune dysregulation in the brain with a goal to develop therapies for childhood brain injury and neurodevelopmental disorders such as cerebral palsy, Rett syndrome, autism, TBI and CNS infections. In collaboration with the Kannan Rangaramanujam lab at the Center for Nanomedicine, Wilmer Eye Institute, the S. Kannan lab has created and developed novel nanotherapies to specifically target immune cells in the brain to promote repair and regeneration. Dr. Kannan is a member of the Society for Neuroscience, the Society of Critical Care Medicine, and the Society for Pediatric Research. She is a fellow of the American Institute for Medical and Biological Engineering. She has published extensively and has won several awards for her research. Dr. Kannan is rated as an Advanced provider by MediFind in the treatment of Zellweger Syndrome. Her top areas of expertise are Traumatic Brain Injury, Zellweger Syndrome, Cerebral Hypoxia, Cerebral Artery Bypass Surgery, and Extracranial-Intracranial Bypass Surgery.